Cardioprotective effects of platycodon grandiflorum granules in HER2-positive early breast cancer patients receiving trastuzumab plus pertuzumab: study protocol for a double blind randomized controlled trial
Open Access
- 12 May 2026
- journal article
- research article
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 26 (1)
Abstract
Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is an aggressive subtype. While trastuzumab plus pertuzumab significantly improves oKeywords
All Related Versions
Funding Information
- Aijian Endowment Fund (AJ005)
This publication has 28 references indexed in Scilit:
- Quality control of Platycodon grandiflorum (Jacq.) A. DC. based on value chains and food chain analysisScientific Reports, 2023
- Can global longitudinal strain (GLS) with magnetic resonance prognosticate early cancer therapy-related cardiac dysfunction (CTRCD) in breast cancer patients, a prospective study?Magnetic Resonance Imaging, 2022
- Platycodon grandiflorum (Jacq.) A. DC.: A review of phytochemistry, pharmacology, toxicology and traditional usePhytomedicine, 2022
- Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based ChemotherapyJAMA Oncology, 2021
- Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendationsAnnals of Oncology, 2020
- A pooled analysis of the cardiac events in the trastuzumab adjuvant trialsBreast Cancer Research and Treatment, 2019
- Role of ACE inhibitors in anthracycline‐induced cardiotoxicity: A randomized, double‐blind, placebo‐controlled trialPediatric Blood & Cancer, 2018
- Effect of prophylactic betablocker or ACE inhibitor on cardiac dysfunction & heart failure during anthracycline chemotherapy ± trastuzumabThe Breast, 2018
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2015
- Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaborationJournal of Clinical Epidemiology, 2006